Skip to main content
Premium Trial:

Request an Annual Quote

Product Watch: Feb 11, 2010

Premium

Fluidigm this week launched its Access Array amplicon-tagging protocol for the Illumina GA II next-generation sequencer.

The 48.48 Access Array integrated fluidic circuit allows Illumina GA II users to automatically prepare sequencing-ready libraries from 48 individual samples at a time for as little as $7 per sample, Fluidigm said.

Fluidigm's Access Array IFC, when used with an Illumina GA II sequencer, can capture up to 12 kb of sequence data per sample, or 576 kb per array. With upcoming applications on the Access Array system, such as long-range PCR, users will be able to target up to 480 kb of sequence data per sample, or 23 MB per array, Fluidigm said.


Integra Biosciences said this week that its Integra Pipetboy pro pipetting aid is now available.

The Pipetboy pro features a white LED light that illuminates the area around the pipette to increase accuracy and reduce eyestrain, the company said, even when dispensing liquids out of an opaque centrifuge tube or dark container, Integra said.

The Pipetboy pro also enables users to pipette by applying variable finger pressure on the pipettor trigger buttons, thereby changing between drop-by-drop or motorized dispensing at an adjustable speed of up to 10 ml/sec.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.